AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

INTELLIGENT ULTRASOUND GROUP PLC

Major Shareholding Notification Sep 4, 2019

7714_rns_2019-09-04_17f7b614-243a-469b-aa1d-04d8e3c65bd0.html

Major Shareholding Notification

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 1152L

Intelligent Ultrasound Group PLC

04 September 2019

Intelligent Ultrasound Group plc

("Intelligent Ultrasound" or the "Group")

Clarification of change of holding

The Board of Intelligent Ultrasound Group plc (AIM: MED) would like to clarify that, following a recent media report, the reduction in the percentage shareholding of IP Group plc and Parkwalk Advisors Limited in the Company announced on 2 September 2019, was as a result of their dilution following the increase in the number of shares in issue subsequent to the oversubscribed Placing and Open Offer which was approved by shareholders on 27 August 2019 and not as a result of any disposal of shares in the Company by IP Group plc or Parkwalk Advisors Limited.

Enquiries:

Intelligent Ultrasound Group plc www.intelligentultrasound.com
Stuart Gall, CEO 

Wilson Jennings, CFO
Tel: +44 (0)29 2075 6534
Cenkos Securities - Nominated Advisor and broker Tel:  +44 (0)20 7397 8900
Giles Balleny / Cameron MacRitchie (Corporate Finance)
Michael Johnson / Julian Morse (Sales)
Walbrook PR Tel: +44 (0)20 7933 8780 or [email protected]
Anna Dunphy / Paul McManus Mob: +44 (0)7876 741 001 / Mob: +44 (0)7980 541 893

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

SPCVXLFBKKFBBBF

Talk to a Data Expert

Have a question? We'll get back to you promptly.